GERD and lung disease

In the March 2014 edition of ACP Internist (American College of Physicians News for Internist publication)  an excellent article by Leah Lawrence  described what is known and not known between a possible link from gastroesophageal reflux disorder (GERD) and pulmonary diseases.  GERD can be asymptomatic and, thus, missed as a possible link to a patient’s pulmonary symptoms. A variety of lung diseases are associated with GERD: asthma, aspiration pneumonia, chronic cough and even idiopathic pulmonary fibrosis (IPF) have been linked. ...

Continue Reading →

COPD and rationale usage of medications

In a GLUCOLD Study from the Neitherlands, by adding inhaled fluticasone (inhaled corticosteroid, ICS) to inhalation therapy in patients with chronic obstructive lung disease (COPD) it was demonstrated to improve “quality of life” parameters, reduce inflammation in patient’s airways (as shown by a reduction of mast cells, neutrophils and eosinophils in sputum, and reduced airways hyper-responsiveness compared to placebo at 6 months of treatment. Cessation of the fluticasone resulted in reversal of benefits back to baseline. This could mean that ...

Continue Reading →